Cabrini Malvern

Malvern, Victoria 3144

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Prevention of Stroke or Systemic Embolism, Triple Negative Breast Cancer

Studies at this site

• Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC — Running, not enrolling
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early